Investing in
Life-Saving Science

Innovestor Life Science Fund

Nordic health-focused fund which loves science and impact


Fund size 90M€
Target sectors Biotech & Digital health
Target geographics Nordics and Baltics
Target stage Pre-seed to Series A
Initial ticket size 250k€ – 3M€

We prefer to syndicate with other specialist investors.

Early-stage Founders:
You don’t need to have it all figured out, we are glad to help.

Our focus areas


  • Strong scientific foundation
  • Strong IP
  • Targeting an unmet clinical need with a well differentiated asset
  • Drug target or mechanism of action that is validated and relevant to human disease or condition
Read moreClose

Digital Health

  • Strong scientific foundation or commitment to generating scientific/clinical evidence
  • Solutions that directly impact the diagnosis, treatment, or management of patients or discovery and development of new diagnostic or treatment options
  • Solutions that have strong IP or data assets, or other barriers to entry
Read moreClose

Our portfolio

We look forward to hearing from you.